MedTrace Logo

A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients

NCT05365191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-05-09

No results posted yet for this study

Summary

This study aims for evaluating near infrared zone II imaging in sentinel lymph node mapping in breast cancer patients.

Conditions

Interventions

PROCEDURE

Near infrared fluorescence navigated sentinel lymph node mapping

Participants undergo sentinel lymph node biopsy for breast cancer, and use blue dye/Tc99m radioisotope as primary tracer. Indocyanine green near infrared fluorescence as secondary tracer for mapping.

Sponsors & Collaborators

  • National Yang Ming Chiao Tung University

    collaborator OTHER

  • National Taiwan University Hospital Hsin-Chu Branch

    lead OTHER

Principal Investigators

  • Yung-Chun Hsieh, MD · National Taiwan University Hospital Hsin-Chu Branch

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-08
Primary Completion
2023-04-07
Completion
2023-04-07

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05365191 on ClinicalTrials.gov